pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›berubicin hydrochloride
drug · small molecule
save

berubicin hydrochloride

Phase 3updated 3mo ago
by $CNSP CNS Pharmaceuticals, Inc.🔗 ChEMBL
Phase 3
community read0 votes

🐶 often sniffed alongside

top 3
  • tagGlioblastoma4 co-mentions · 1 sources
  • companyAnthem Biosciences Ltd1 co-mentions · 1 sources
  • tagOncology1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 4 investigational indications.

targets

DNA topoisomerase II

all catalysts(1)

phase 2 3 completion · 1
Apr 27, 2026
phase 2 3 completion
4mo ago
Anthem Biosciences Ltd — berubicin hydrochloride (Phase II/III Trial Completion)
berubicin hydrochloride
→

Trials studying berubicin hydrochloride

  • phase2RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastasesterminatedn=14
  • phase2Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)terminatedn=5
  • phase1A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomaswithdrawn

News(0)

no news has mentioned this drug yet

generic
berubicin hydrochloride
MOA
DNA topoisomerase II inhibitor
indication
Recurrent Glioblastoma Multiforme (GBM)
phase
phase_3
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 35m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?